The gap between its revenue multiple and its cash multiple is margin, and the company is spending it on purpose.

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

ADUS vs. ELAN: Which Stock Is the Better Value Option?

Here is how Novavax (NVAX) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.

Addus HomeCare (ADUS) reported impressive Q2 organic growth across its core personal care and hospic

Addus HomeCare Corp (ADUS) reports 8% revenue growth and 16.1% adjusted EPS increase, while navigating hospice Medicare cap accruals and home health segment challenges.

Addus HomeCare (NASDAQ:ADUS) reported second-quarter 2026 revenue growth of 8% and adjusted earnings-per-share growth of 16.1%, supported by expansion in personal care and hospice services, improved cash generation and ongoing acquisition activity. Total net service revenues rose to $377.4 million

Addus HomeCare Corporation has now reported its second-quarter and first-half 2026 results, with Q2 net income of US$27.61 million and diluted EPS from continuing operations of US$1.49, both higher than the same periods in 2025. Alongside this, the company’s non-GAAP earnings per share modestly outpaced analyst expectations while maintaining an 11.5% adjusted operating margin, underscoring consistent profitability on essentially flat margins year over year. We’ll now examine how this...

Addus HomeCare (ADUS) attracted fresh attention after its Q2 2026 results, which matched Wall Street revenue expectations. Non-GAAP earnings per share and operating margins came in slightly ahead and remained steady year on year. See our latest analysis for Addus HomeCare. At a share price of $116.79, Addus HomeCare has seen a 30-day share price return of 11.05% and a 90-day share price return of 20.85%. The 1-year total shareholder return of 0.19% suggests recent momentum is building off a...

The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Addus HomeCare (ADUS) delivered earnings and revenue surprises of +2.37% and +0.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8% year on year to $377.4 million. Its non-GAAP profit of $1.73 per share was 1.9% above analysts’ consensus estimates.

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday after market hours. Here’s what you need to know.

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

The telehealth company is making a bold pivot that's driving growth, but the stock's recent slide has investors wondering if the price of admission is still too high.

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

Addus HomeCare Corporation (NASDAQ:ADUS) is one of the best small cap stocks to buy with the highest upside potential. Barclays lifted the price target on Addus HomeCare Corporation (NASDAQ:ADUS) to $96 from $92 on July 8 and maintained an Underweight rating on the shares. The firm adjusted price targets among its U.S. healthcare facilities and managed […]